BIOMAT Database Logo BIOMAT Database Logo

Clinical studies with daunorubicin-DNA and adriamycin-DNA complexes: a review. 1979

A Trouet, and G Sokal

The clinical results presently available on the use of daunorubicin (DNR)-DNA and Adriamycin (ADR)-DNA are reviewed in light of the most recent experimental data regarding the anthracycline-DNA complexes. Three randomized trials indicate that ADR-DNA is superior to DNR-DNA in combination therapy for acute lymphoblastic leukemia, that DNR-DNA equals DNR in the treatment of acute nonlymphoblastic leukemia, and that ADR-DNA might be equal to ADR in the chemotherapy for anaplastic bronchogenic carcinoma. Increasing evidence suggests that the anthracycline-DNA complexes are less cardiotoxic than the corresponding free drugs.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell

Related Publications

A Trouet, and G Sokal
Letter: DNA complexes of daunorubicin (NSC-8215) and adriamycin (NSC-123127).
January 1975, Cancer chemotherapy reports,
A Trouet, and G Sokal
Fate of DNA and its complexes with daunorubicin and adriamycin in rat fibroblasts [proceedings].
February 1977, Archives internationales de physiologie et de biochimie,
A Trouet, and G Sokal
Iron(III)-adriamycin and Iron(III)-daunorubicin complexes: physicochemical characteristics, interaction with DNA, and antitumor activity.
January 1985, Biochemistry,
A Trouet, and G Sokal
Interaction of new derivatives of daunorubicin and adriamycin with DNA.
May 1977, Il Farmaco; edizione scientifica,
A Trouet, and G Sokal
DNA--anthracycline complexes. I. Toxicity in mice and chemotherapeutic activity against L1210 leukemia of daunorubicin--DNA and adriamycin--DNA.
August 1980, European journal of cancer,
A Trouet, and G Sokal
Resonance Raman spectroscopic studies of adriamycin and copper(II)-adriamycin and copper(II)-adriamycin-DNA complexes.
February 1986, Biochemistry,
A Trouet, and G Sokal
Adriamycin and daunorubicin inhibition of mutant T4 DNA polymerases.
April 1974, Proceedings of the National Academy of Sciences of the United States of America,
A Trouet, and G Sokal
Daunorubicin-DNA and doxorubicin-DNA. A review of experimental and clinical data.
January 1979, Cancer chemotherapy and pharmacology,
A Trouet, and G Sokal
Direct in vitro photoaffinity labeling of DNA with daunorubicin, adriamycin, and rubidazone.
November 1979, Biochimica et biophysica acta,
A Trouet, and G Sokal
Clinical trials with daunorubicin-DNA and adriamycin-DNA in acute lymphoblastic leukemia of childhood, acute nonlymphoblastic leukemia, and bronchogenic carcinoma.
January 1979, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!